Louise J. Eltringham‐Smith

547 total citations
28 papers, 443 citations indexed

About

Louise J. Eltringham‐Smith is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Louise J. Eltringham‐Smith has authored 28 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 6 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Louise J. Eltringham‐Smith's work include Blood Coagulation and Thrombosis Mechanisms (12 papers), Platelet Disorders and Treatments (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). Louise J. Eltringham‐Smith is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (12 papers), Platelet Disorders and Treatments (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). Louise J. Eltringham‐Smith collaborates with scholars based in Canada, Egypt and United States. Louise J. Eltringham‐Smith's co-authors include William P. Sheffield, Varsha Bhakta, Donald M. Arnold, Mark Crowther, Alison Fox‐Robichaud, Jeffrey I. Weitz, Syed M. Qadri, Alan R. Stafford, Megan E. Begbie and Dhruva J. Dwivedi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and The Journal of Organic Chemistry.

In The Last Decade

Louise J. Eltringham‐Smith

28 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Louise J. Eltringham‐Smith Canada	11	148	132	110	71	71	28	443
Xunzhen Zheng United States	10	216 1.5×	158 1.2×	40 0.4×	36 0.5×	81 1.1×	15	531
Susanne Zieseniss Germany	5	217 1.5×	178 1.3×	81 0.7×	82 1.2×	20 0.3×	5	495
A R L Gear United States	14	188 1.3×	141 1.1×	88 0.8×	34 0.5×	44 0.6×	23	547
Teshell K. Greene United States	7	240 1.6×	89 0.7×	58 0.5×	65 0.9×	20 0.3×	10	496
Xinmiao Wang China	10	107 0.7×	204 1.5×	50 0.5×	15 0.2×	61 0.9×	25	496
Sumith R. Panicker United States	12	87 0.6×	109 0.8×	33 0.3×	38 0.5×	21 0.3×	23	395
Iván Parra‐Izquierdo United States	11	77 0.5×	90 0.7×	141 1.3×	18 0.3×	17 0.2×	18	335
Machteld Sillen Belgium	7	100 0.7×	88 0.7×	42 0.4×	27 0.4×	36 0.5×	8	323
Padmaja Mehta-D’souza United States	12	73 0.5×	179 1.4×	16 0.1×	27 0.4×	37 0.5×	22	560
Sara Calzavarini Switzerland	10	170 1.1×	176 1.3×	38 0.3×	37 0.5×	25 0.4×	18	470

Countries citing papers authored by Louise J. Eltringham‐Smith

Since Specialization

Citations

This map shows the geographic impact of Louise J. Eltringham‐Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louise J. Eltringham‐Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louise J. Eltringham‐Smith more than expected).

Fields of papers citing papers by Louise J. Eltringham‐Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louise J. Eltringham‐Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louise J. Eltringham‐Smith. The network helps show where Louise J. Eltringham‐Smith may publish in the future.

Co-authorship network of co-authors of Louise J. Eltringham‐Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Louise J. Eltringham‐Smith. A scholar is included among the top collaborators of Louise J. Eltringham‐Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louise J. Eltringham‐Smith. Louise J. Eltringham‐Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bhakta, Varsha, et al.. (2024). Extension of the circulatory half-life of recombinant ecallantide via albumin fusion without loss of anti-kallikrein activity. Journal of Biotechnology. 391. 11–19. 1 indexed citations

Eltringham‐Smith, Louise J., Scott C. Meixner, Edward L.G. Pryzdial, & William P. Sheffield. (2023). Correction of haemorrhagic shock-associated coagulopathy and impaired haemostasis by plasma, prothrombin complex concentrates or an activated protein C-targeted DNA aptamer in mice. Scientific Reports. 13(1). 3811–3811. 1 indexed citations

Eltringham‐Smith, Louise J., et al.. (2022). Spotlight on animal models of acute traumatic coagulopathy: an update. Transfusion and Apheresis Science. 61(2). 103412–103412. 6 indexed citations

Eltringham‐Smith, Louise J., Varsha Bhakta, & William P. Sheffield. (2021). Selection and in vitro and in vivo characterization of a Kunitz protease inhibitor domain of protease nexin 2 variant that inhibits factor XIa without inhibiting plasmin. Journal of Biotechnology. 330. 61–69. 4 indexed citations

Eltringham‐Smith, Louise J., Ruoying Yu, Syed M. Qadri, et al.. (2019). Prothrombin, alone or in complex concentrates or plasma, reduces bleeding in a mouse model of blood exchange-induced coagulopathy. Scientific Reports. 9(1). 13029–13029. 2 indexed citations

Sheffield, William P., Louise J. Eltringham‐Smith, & Varsha Bhakta. (2018). A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss. BMC Biotechnology. 18(1). 21–21. 10 indexed citations

Bhakta, Varsha, et al.. (2017). Selection and characterization of a DNA aptamer inhibiting coagulation factor XIa. Scientific Reports. 7(1). 2102–2102. 42 indexed citations

Pryzdial, Edward L.G., Scott C. Meixner, Louise J. Eltringham‐Smith, et al.. (2016). Thrombolysis by chemically modified coagulation factor Xa. Journal of Thrombosis and Haemostasis. 14(9). 1844–1854. 6 indexed citations

Sheffield, William P., et al.. (2014). A plasmin-activatable thrombin inhibitor reduces experimental thrombosis and assists experimental thrombolysis in murine models. Journal of Thrombosis and Thrombolysis. 39(4). 443–451. 10 indexed citations

10.

Sheffield, William P., et al.. (2014). γT‐S195A thrombin reduces the anticoagulant effects of dabigatran in vitro and in vivo. Journal of Thrombosis and Haemostasis. 12(7). 1110–1115. 10 indexed citations

11.

Bhakta, Varsha, et al.. (2012). In VivoClearance of Alpha-1 Acid Glycoprotein Is Influenced by the Extent of Its N-Linked Glycosylation and by Its Interaction with the Vessel Wall. SHILAP Revista de lepidopterología. 2012. 1–11. 11 indexed citations

12.

Eltringham‐Smith, Louise J., et al.. (2012). Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate. Journal of Thrombosis and Haemostasis. 10(9). 1830–1840. 74 indexed citations

13.

Eltringham‐Smith, Louise J., et al.. (2012). Reduction of thrombus size in murine models of thrombosis following administration of recombinant α1-proteinase inhibitor mutant proteins. Thrombosis and Haemostasis. 107(5). 972–984. 16 indexed citations

14.

Bold, Mercedes L. Kuroski de, et al.. (2012). Characterization of a long-acting recombinant human serum albumin-atrial natriuretic factor (ANF) expressed in Pichia pastoris. Regulatory Peptides. 175(1-3). 7–10. 21 indexed citations

15.

Sheffield, William P. & Louise J. Eltringham‐Smith. (2011). Incorporation of albumin fusion proteins into fibrin clots in vitro and in vivo: comparison of different fusion motifs recognized by factor XIIIa. BMC Biotechnology. 11(1). 127–127. 6 indexed citations

16.

Bhakta, Varsha, et al.. (2011). Comparison of Methods for the Purification of Alpha‐1 Acid Glycoprotein from Human Plasma. BioMed Research International. 2011(1). 578207–578207. 5 indexed citations

17.

Sheffield, William P., et al.. (2006). Combined administration of barbourin–albumin and hirudin–albumin fusion proteins limits fibrin(ogen) deposition on the rabbit balloon-injured aorta. Thrombosis Research. 119(2). 195–207. 4 indexed citations

18.

Eltringham‐Smith, Louise J., et al.. (2005). Recombinant albumins containing additional peptide sequences smaller than barbourin retain the ability of barbourin-albumin to inhibit platelet aggregation. Thrombosis and Haemostasis. 93(5). 914–921. 8 indexed citations

19.

Begbie, Megan E., et al.. (2005). An important role for the activation peptide domain in controlling factor IX levels in the blood of haemophilia B mice. Thrombosis and Haemostasis. 94(12). 1138–1147. 19 indexed citations

20.

Sheffield, William P., et al.. (2004). Effects of genetic fusion of factor IX to albumin on in vivo clearance in mice and rabbits. British Journal of Haematology. 126(4). 565–573. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact